Catherine Saï-Maurel

525 total citations
24 papers, 422 citations indexed

About

Catherine Saï-Maurel is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Catherine Saï-Maurel has authored 24 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Catherine Saï-Maurel's work include Radiopharmaceutical Chemistry and Applications (22 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Medical Imaging Techniques and Applications (4 papers). Catherine Saï-Maurel is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (22 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Medical Imaging Techniques and Applications (4 papers). Catherine Saï-Maurel collaborates with scholars based in France, United States and Tunisia. Catherine Saï-Maurel's co-authors include Jacques Barbet, Alain Faivre-Chauvet, Françoise Kraeber‐Bodéré, Philippe Thédrez, Michel Chérel, Jean‐François Gestin, Emmanuel Gautherot, Mickaël Bourgeois, J.F. Chatal and Sébastien Gouard and has published in prestigious journals such as International Journal of Cancer, International Journal of Pharmaceutics and RSC Advances.

In The Last Decade

Catherine Saï-Maurel

24 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Saï-Maurel France	14	323	126	84	64	38	24	422
Philippe Thédrez France	17	464 1.4×	120 1.0×	100 1.2×	92 1.4×	36 0.9×	31	617
Catherine Maurel France	14	299 0.9×	144 1.1×	87 1.0×	115 1.8×	11 0.3×	25	476
Melissa Nelson United States	11	208 0.6×	197 1.6×	185 2.2×	53 0.8×	63 1.7×	21	516
Beatrix Stelte‐Ludwig Germany	11	163 0.5×	245 1.9×	150 1.8×	101 1.6×	37 1.0×	39	574
Vania Kenanova United States	15	675 2.1×	271 2.2×	360 4.3×	78 1.2×	18 0.5×	20	862
Warak Chaovapong United States	7	310 1.0×	122 1.0×	112 1.3×	30 0.5×	41 1.1×	10	405
G. Rowlinson United Kingdom	7	285 0.9×	122 1.0×	94 1.1×	49 0.8×	25 0.7×	10	435
J.C. Saccavini France	12	382 1.2×	104 0.8×	120 1.4×	72 1.1×	13 0.3×	25	493
Kelly Davis Orcutt United States	13	334 1.0×	155 1.2×	201 2.4×	40 0.6×	23 0.6×	25	510
Erasmus Poku United States	14	419 1.3×	302 2.4×	156 1.9×	97 1.5×	26 0.7×	33	660

Countries citing papers authored by Catherine Saï-Maurel

Since Specialization

Citations

This map shows the geographic impact of Catherine Saï-Maurel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Saï-Maurel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Saï-Maurel more than expected).

Fields of papers citing papers by Catherine Saï-Maurel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Saï-Maurel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Saï-Maurel. The network helps show where Catherine Saï-Maurel may publish in the future.

Co-authorship network of co-authors of Catherine Saï-Maurel

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Saï-Maurel. A scholar is included among the top collaborators of Catherine Saï-Maurel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Saï-Maurel. Catherine Saï-Maurel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bris, Nathalie Le, Clément Bailly, Catherine Saï-Maurel, et al.. (2019). TE1PA as Innovating Chelator for ⁶⁴Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 mAb in a Syngeneic Multiple Myeloma Model. Bioconjugate Chemistry. 30(9). 2393–2403. 22 indexed citations

Gouard, Sébastien, Catherine Saï-Maurel, François Guérard, et al.. (2018). Efficacy of Astatine-211 radioimmunotherapy of Multiple Myeloma using an anti-mCD138 monoclonal antibody in a syngeneic murine model. European Journal of Nuclear Medicine and Molecular Imaging. 45(1). 1 indexed citations

Beyler, Maryline, Catherine Saï-Maurel, Cyrille Alliot, et al.. (2017). Cyclam te1pa for⁶⁴Cu PET imaging. Bioconjugation to antibody, radiolabeling and preclinical application in xenografted colorectal cancer. RSC Advances. 7(15). 9272–9283. 17 indexed citations

Carlier, Thomas, et al.. (2016). Are macroscopic PET textural features representative of microscopic heterogeneity? A preliminary simple and direct comparison between PET and digital autoradiography.. 57. 1407–1407. 1 indexed citations

Chérel, Michel, Sébastien Gouard, Joëlle Gaschet, et al.. (2013). ²¹³Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma. Journal of Nuclear Medicine. 54(9). 1597–1604. 58 indexed citations

Rousseau, Caroline, A. Ruellan, Karine Bernardeau, et al.. (2011). Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors. EJNMMI Research. 1(1). 20–20. 34 indexed citations

Kraeber‐Bodéré, Françoise, Caroline Bodet‐Milin, Colin Niaudet, et al.. (2010). Comparative Toxicity and Efficacy of Combined Radioimmunotherapy and Antiangiogenic Therapy in Carcinoembryonic Antigen–Expressing Medullary Thyroid Cancer Xenograft. Journal of Nuclear Medicine. 51(4). 624–631. 18 indexed citations

Thédrez, Philippe, Julie Lesieur, Catherine Saï-Maurel, et al.. (2009). Biodistribution and Tumor Targeting of Indium and Iodine-labeled Shiga Toxin B-Subunit. Current Radiopharmaceuticals. 2(3). 184–190. 3 indexed citations

Mougin‐Degraef, Marie, Catherine Saï-Maurel, Mickaël Bourgeois, et al.. (2007). Doubly radiolabeled liposomes for pretargeted radioimmunotherapy. International Journal of Pharmaceutics. 344(1-2). 110–117. 26 indexed citations

10.

Mirallié, Éric, Catherine Saï-Maurel, Alain Faivre-Chauvet, et al.. (2005). Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody. European Journal of Nuclear Medicine and Molecular Imaging. 32(8). 901–909. 17 indexed citations

11.

Kraeber‐Bodéré, Françoise, Catherine Saï-Maurel, L. Campion, et al.. (2002). Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.. PubMed. 1(4). 267–74. 30 indexed citations

12.

Bardiès, Manuel, Emmanuel Gautherot, Anne Gruaz‐Guyon, et al.. (2001). Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.. PubMed. 42(1). 146–53. 41 indexed citations

13.

Kraeber‐Bodéré, Françoise, Alain Faivre-Chauvet, Catherine Saï-Maurel, et al.. (1999). Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.. PubMed. 5(10 Suppl). 3183s–3189s. 25 indexed citations

14.

Gautherot, Emmanuel, Françoise Kraeber‐Bodéré, Laurent Daniel, et al.. (1999). Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.. PubMed. 5(10 Suppl). 3177s–3182s. 7 indexed citations

15.

Kraeber‐Bodéré, Françoise, Catherine Saï-Maurel, Emmanuel Gautherot, et al.. (1999). Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.. PubMed. 40(1). 198–204. 31 indexed citations

16.

Devys, Anne, Philippe Thédrez, Emmanuel Gautherot, et al.. (1996). Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques. International Journal of Cancer. 67(6). 883–891. 13 indexed citations

17.

Gestin, Jean‐François, Alain Faivre-Chauvet, Ronnie C. Mease, et al.. (1993). Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab′)2 fragments of anti-carcinoembryonic antigen antibody—I. A new reproducible synthetic method. Nuclear Medicine and Biology. 20(6). 755–762. 4 indexed citations

18.

Curtet, C., Alain Faivre-Chauvet, Catherine Saï-Maurel, et al.. (1993). Biodistribution of anti-CEA F(ab′)2 fragments conjugated with chelating polymers: Influence of conjugate electron charge on tumor uptake and blood clearance. Nuclear Medicine and Biology. 20(4). 443–452. 13 indexed citations

19.

Faivre-Chauvet, Alain, Jean‐François Gestin, Ronnie C. Mease, et al.. (1993). Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab′)2 fragments of anti-carcinoembryonic antigen antibody—II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice. Nuclear Medicine and Biology. 20(6). 763–771. 9 indexed citations

20.

Curtet, C., et al.. (1992). Site-specific conjugation of chain-terminal chelating polymers to Fab' fragments of anti-CEA mAb: Effect of linkage type and polymer size on conjugate biodistribution in nude mice bearing human colorectal carcinoma. Bioconjugate Chemistry. 3(6). 477–483. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact